The latest news from Sutura

Stay up-to-date with Sutura Therapeutics' latest innovations and advancements by visiting our newsroom regularly.

Edwin Wagena 24/06/2024 Edwin Wagena 24/06/2024

The Promise of Stabilised CPPs in Intracellular Delivery

Explore how Sutura Therapeutics' innovative stabilised CPPs are revolutionising intracellular delivery of macromolecular payloads.

Edwin Wagena 18/06/2024 Edwin Wagena 18/06/2024

Learn about groundbreaking efforts to revolutionise Pompe disease treatment and improve patient outcomes in the face of current therapy limitations.

Edwin Wagena 01/05/2024 Edwin Wagena 01/05/2024

Discover how Sutura's groundbreaking research at BioTrinity 2024 is setting the stage for advances in healthcare and biotechnology.

Edwin Wagena 12/04/2024 Edwin Wagena 12/04/2024

Join our CEO, Edwin Wagena, at BioTrinity 2024 to explore the future of biotech and discover more about our cutting-edge drug conjugate platform.

Edwin Wagena 15/09/2022 Edwin Wagena 15/09/2022

Do you have a question about the innovative technology behind Sutura’s groundbreaking Drug Conjugate Platform? We’re so glad you asked!